baber/WOPTO huggingface dataset:
Patent AU-2009265996-B2 (AU)
Title: Wound dressing
Inventor: JUNGINGER MARTIN
IPC: A61F13/00
Filed: 2009-07-01
Granted: 2014-10-16
Abstract: The present invention relates to a multi-layered wound dressing, particularly for the wound treatment in the granulation and epithelization phases. The wound dressing comprises a) a first layer as a wound contact layer, having a first side and a second side, and b) at least a second layer as an absorbing layer, having a first side and a second side, which comprises a hydrophilic polyurethane foam, wherein the polyurethane foam comprises a water content of at least 10% by weight.
Patent AU-2009325117-B2 (AU)
Title: Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
Inventor: TRAN THUY-ANH
IPC: A61K31/416
Filed: 2009-11-24
Granted: 2014-07-10
Abstract: Pyrazole derivatives of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of: pulmonary arterial hypertension (PAH) and related disorders; platelet aggregation; coronary artery disease; myocardial infarction; transient ischemic attack; angina; stroke; ischemia-reperfusion injury; restenosis; atrial fibrillation; blood clot formation in an angioplasty or coronary bypass surgery individual or in an individual suffering from atrial fibrillation; atherosclerosis; atherothrombosis; asthma or a symptom thereof; a diabetic-related disorder such as diabetic peripheral neuropathy, diabetic nephropathy or diabetic retinopathy; glaucoma or other disease of the eye with abnormal intraocular pressure; hypertension; inflammation; psoriasis; psoriatic arthritis; rheumatoid arthritis; Crohn's disease; transplant rejection; multiple sclerosis; systemic lupus erythematosus (SLE); ulcerative colitis; ischemia-reperfusion injury; restenosis; atherosclerosis; acne; type 1 diabetes; type 2 diabetes; sepsis; and chronic obstructive pulmonary disorder (COPD).
Patent AU-2009355842-B2 (AU)
Title: Method and system for filtering image data and use thereof in virtual endoscopy
Inventor: VINCENT THOMAS BERNARD PASCAL
IPC: A61B6/03
Filed: 2009-11-27
Granted: 2016-04-21
Abstract: A method for filtering image data having at least three types of distinct regions from a selected type of region, each of the at least three types of distinct regions being characterized by a plurality of unitary image elements, the method comprising providing the image data; selecting a portion of the image data comprising at least a corresponding portion of each of the at least three types of regions; determining at least one distribution for each of the at least three types of regions in the selected portion; determining at least one function for associating each unitary image element of the selected type of region in the selected portion to another type of region of the at least three types of regions such that the at least one distribution of the selected type of regions in the selected portion is transposed into a corresponding distribution of the another type of region; and applying the at least one function to each unitary image element of the selected type of region of the selected portion to thereby provide filtered image data. Applications of the method for suppressing tagged material in virtual colonoscopy are also disclosed.
Patent AU-2010239378-B2 (AU)
Title: Colon lavage system
Inventor: BACHWICH DALE R
IPC: A23L27/00
Filed: 2010-04-20
Granted: 2013-11-21
Abstract: The present invention provides compositions, systems, kits, and methods for preparation prior to a colonoscopy or other gastrointestinal procedure. In particular, the present invention provides a colon lavage system comprising an aqueous portion and a solid portion.
Patent AU-2010244348-B2 (AU)
Title: Oncolytic adenoviruses for treating cancer
Inventor: GUEDAN CARRIO SONIA
IPC: A61K35/761
Filed: 2010-05-05
Granted: 2016-08-11
Abstract: The invention relates to an oncolytic adenovirus that comprises a sequence that encodes a hyaluronidase enzyme inserted in the genome thereof. This adenovirus is distributed more efficiently through the mass of the tumour and consequently the oncolytic effect is enhanced. Endovenous injection of the oncolytic adenovirus of the invention gives rise to regressions in tumour volume. Therefore, the oncolytic adenovirus of the present invention can be used to treat cancer or a pre-malignant stage thereof.
Patent AU-2010250789-B2 (AU)
Title: Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists
Inventor: BUR DANIEL
IPC: C07D277/62
Filed: 2010-05-17
Granted: 2015-05-14
Abstract: The present invention relates to bridged spiro[2.4]heptane derivatives of formula (I), wherein W, Y, Z, R
Patent AU-2011205103-B2 (AU)
Title: Trackless transit system with adaptive vehicles
Inventor: KOON PHILLIP L
IPC: G08G1/0968
Filed: 2011-08-01
Granted: 2014-10-02
Abstract: TRACKLESS TRANSIT SYSTEM WITH ADAPTIVE VEHICLES 5 Technologies are described herein for providing a trackless transit system and controlling adaptive trackless vehicles within that system. Aspects include an autonomous vehicle transit system for controlling vehicle movement of trackless vehicles 102 in the transit system. The system includes a command, control and orchestration system (CCOS) 106 and vehicle controllers 202. Each vehicle controller 202 is associated with a trackless vehicle 102 and 0 communicates a current location to the CCOS 106, receives a navigation command, and controls the trackless vehicle 102 according to the navigation command. Further, the CCOS 106 provides navigation commands to the vehicle controllers 202 to control movements of the trackless vehicles 102 within the transit system according to vehicle position information received from the vehicle controllers 202. According to embodiments, a trackless vehicle 102 may be switched 5 between a driver controlled mode in which the vehicle 102 is controlled by a driver and a system controlled mode in which the vehicle is controlled by the CCOS 106. P006292 (5471660_1.DOCX) ci) U) z 00 < - Z) oJ 0o <LUj 0 LUi LU -j LU LUI 0U > zoo LU > UJ o W-i - r 2(0 l
Patent AU-2011207257-B2 (AU)
Title: Immunoregulation by anti-ILT5 antibodies and ILT5-binding antibody fragments
Inventor: APOSTOLOU IRINA
IPC: A61K39/395
Filed: 2011-01-20
Granted: 2016-03-03
Abstract: Disclosed herein are methods of using anti-ILT5 antibodies and ILT5-binding fragments thereof to induce an immunostimulatory effect in a T cell when such a T cell is contacted with an antigen presenting cell (APC) that has been previously contacted with the anti-ILT5 antibody or ILT5-binding fragment. Also disclosed herein are methods of using anti-ILT5 antibodies and ILT5-binding fragments thereof to inhibit a response in a T cell (e.g., a proliferative response) when such a T cell is concomitantly contacted, or has previously been contacted, with an APC, which APC is simultaneously contacted with the anti-ILT5 antibody or ILT5-binding fragment. Also disclosed herein are methods of using anti-ILT5 antibodies and ILT5-binding fragments thereof for the treatment of various diseases and for use as immunostimulatory adjuvants.
Patent AU-2011220886-B2 (AU)
Title: High efficiency roller shade
Inventor: MULLET WILLIS JAY
IPC: A47G5/02
Filed: 2011-02-23
Granted: 2015-12-24
Abstract: The present invention advantageously provides a motorized roller shade that includes a shade tube, a motor/controller unit and a power supply unit. The motor/controller unit is disposed within the shade tube, and includes a bearing, rotatably coupled to a support shaft, and a DC gear motor. The output shaft of the DC gear motor is coupled to the support shaft such that the output shaft and the support shaft do not rotate when the support shaft is attached to the mounting bracket.
Patent AU-2011224244-B2 (AU)
Title: Adjustable reduced-pressure wound coverings
Inventor: LOCKE CHRISTOPHER BRIAN
IPC: A61M1/00
Filed: 2011-03-10
Granted: 2016-03-03
Abstract: Adjustable covers, systems, and methods are presented that include an adjustable cover that may be adjusted to an appropriate size by hand without requiring cutting tools and without substantial leaks. In one instance, the adjustable covering includes a drape member with a plurality of non-leaking tear paths. Each non-leaking tear path includes a weakened path of the drape member that may be torn. The adjustable covering may further include a first plurality of tear starters formed on a first initiation edge of the drape member. Each tear starter of the first plurality of tear starters is aligned with one of the plurality of tear paths. Each of the first plurality of tear starters is adapted to facilitate the initiation of a tear along a tear path. The grains of the drape member, a backing layer, and support layer may also be in the same direction. Other adjustable covers, systems, and methods are presented.
Patent AU-2011231570-B2 (AU)
Title: Electro-mechanical drug delivery device
Inventor: WIMPENNY STEVEN
IPC: A61M5/00
Filed: 2011-03-25
Granted: 2014-08-21
Abstract: An electro-mechanical drug delivery device (800, 821, 850, 952) comprises a main body (802, 822, 852, 902, 956) having a distal end (808, 828, 910) and a proximal end (806, 826, 958). The distal end (808, 828, 910) is configured to attach to a dispense interface. A separable housing (804, 824, 854, 904, 962) that can prevent an administration of a drug by the drug delivery device (800, 821, 850, 952), the housing configured to cover at least a portion of the distal end (808, 828, 910) of the main body (802, 822, 852, 902, 956) when the separable housing (804, 824, 854, 904, 962) is coupled to the main body (802, 822, 852, 902, 956) of the drug delivery device (800, 821, 850, 952). A conduction element (856, 906) is provided by the main body (802, 822, 852, 902, 956) and configured for establishing an electrical connection with an electrical connector (849, 862, 968). Establishment of the electrical connection is prevented when the housing does not cover at least a portion of the distal end (808, 828, 910) of the main body (802, 822, 852, 902, 956). The electrical connection may be established when the housing covers at least a portion of the distal end (808, 828, 910) of the main body (802, 822, 852, 902, 956) of the drug delivery device (800, 821, 850, 952).
Patent AU-2011258700-B2 (AU)
Title: Determining spatial orientation information of a body from multiple electromagnetic signals
Inventor: WELLINGTON ROBERT J
IPC: G01S5/02
Filed: 2011-05-18
Granted: 2015-07-02
Abstract: A method for determining a spatial orientation of a body, including receiving, by receiving equipment located with the body, at least three electromagnetic signal sets, each of the received signal sets having been transmitted by a different one of at least three separate transmitters at different locations, detecting, for each one of the received signal sets, information that partially defines a direction from the body to the transmitter from which the signal set was received, the detected information including one of two angles that fully define an arrival direction from which the body received the signal set in relation to a body frame, the detected information not including a second of the two angles, and determining the spatial orientation of the body, including yaw, pitch, and roll angles relative to a navigation frame, using the detected information for each one of the received signal sets.
Patent AU-2011280985-B2 (AU)
Title: Methods of treating or ameliorating diseases and enhancing performance comprising the use of a magnetic dipole stabilized solution
Inventor: HAROON ZISHAN
IPC: A23L2/00
Filed: 2011-07-22
Granted: 2015-10-08
Abstract: The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.
Patent AU-2011293785-B2 (AU)
Title: Methods of preparing a crossliked fiber membrane
Inventor: HUSAIN SHABBIR
IPC: B01D71/64
Filed: 2011-08-09
Granted: 2013-11-28
Abstract: Disclosed herein is a method for preparing a crosslinked hollow fiber membrane. The method involves spinning a one phase solution comprising a monoesterified polyimide polymer, acetone as a volatile solvent, a spinning solvent, a spinning non-solvent, and optionally an organic and/or inorganic additive, wherein the volatile solvent is present in an amount of greater than 25 wt. % to about 50 wt. %, based on the total weight of the solution.
Patent AU-2011315926-B2 (AU)
Title: Quantitative multiplexed identification of nucleic acid targets
Inventor: SPIZZ GWENDOLYN
IPC: C12Q1/68
Filed: 2011-10-14
Granted: 2015-12-10
Abstract: Methods and systems for detecting a target nucleic acid using the quantitative capabilities of real-time nucleic acid amplification systems and the multiplexing capabilities of hybridization systems, comprising: identifying a conservative sequence and a distinctive sequence within each target nucleic acid sequence; simultaneously amplifying the conservative region and the distinctive region; monitoring the amplification of the conservative region in real-time; identifying the distinctive region amplicon via multiplexed identification; and performing quantitative multiplexing analysis of the target by combining the real-time monitoring information with the multiplexed identification of the target nucleic acid.
Patent AU-2011334515-B2 (AU)
Title: Fail safe locking overshot device
Inventor: SALVADOR PATRICK
IPC: E21B31/18
Filed: 2011-11-22
Granted: 2016-09-08
Abstract: A fail safe locking overshot device. The overshot device is connected to a hoisting line for retrieval of a spearhead. The device provides automatic engagement of a mechanical locking system through locking dogs for locking the lifting dogs after capture of a spearhead. Manual disengagement is required to unlock the lifting dogs and release the spearhead.
Patent AU-2011341526-B2 (AU)
Title: Microporous material containing a security feature
Inventor: BENENATI PAUL L
IPC: B29C48/395
Filed: 2011-11-29
Granted: 2015-06-04
Abstract: Provided is a microporous material, e.g., a microporous sheet material, having a matrix of polyolefin, finely-divided, substantially water insoluble particulate filler, a network of interconnecting pores communicating throughout the microporous material, and at least one retrospectively identifiable taggant material embedded within the matrix, optionally the at least one taggant being unique to an end user for the microporous material, wherein the polyolefin is present in the microporous material in an amount of 20 to 35 weight percent, based on the weight of the microporous material. The taggant material provides a marker, signature or code that is capable of retrospective identification by machine, instrument or by the naked eye. Articles including the microporous material and processes for preparing the microporous material also are provided.
Patent AU-2011342875-B2 (AU)
Title: Cartridge for preparing a liquid product
Inventor: VANNI ALFREDO
IPC: B65D85/804
Filed: 2011-12-07
Granted: 2015-12-24
Abstract: A cartridge (10) for preparing a liquid product, for example a beverage such as coffee by introducing liquid and/or steam into the cartridge (10) contains a dose (12) of at least one substance, such as for example powdered coffee, which is able to form the aforesaid product using said liquid and/or steam. The dose is enclosed between foils (14, 16) that can be traversed by the aforesaid liquid and/or steam, said foils (14, 16) being connected together around the dose (12). The aforesaid foils (14, 16) are made of compostable material, i.e., a material that can be recovered by composting and biodegradation, and are connected together around the dose (12) using a connecting material (30), which is also compostable. The cartridge as a whole can hence be recovered by composting and biodegradation, in compliance with the European Norm UNI EN 13432:2002 and/or subsequent modifications and integrations thereof.
Patent AU-2012200168-B2 (AU)
Title: Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
Inventor: HANSEN HANS J
IPC: A61K39/00
Filed: 2012-01-12
Granted: 2013-10-03
Abstract: C:\NRPonbI\DCC\SZPW4067407_ LDOC.22112/2011 Methods and compositions for immunotherapy of inflammatory and immune dysregulatory diseases, using multispecific antagonists that target at least two different markers are disclosed. The different targets include (i) proinflammatory effectors of the innate immune system, (ii) coagulation factors, and (iii) targets specifically associated with an inflammatory or immune-dysregulatory disorder, with a pathologic angiogenesis or cancer, or with an infectious disease, wherein the targets included in group (iii) are neither a proinflammatory effector of the immune system nor a coagulation factor. When the multispecific antagonist reacts specifically with a target associated with an inflammatory or immune-dysregulatory disorder, with a pathologic angiogenesis or cancer, or with an infectious disease, it also binds specifically with at least one proinflammatory effector of the immune system or at least one coagulation factor. Thus, the multispecific antagonist contains at least one binding specificity related to the diseased cell or condition being treated and at least one specificity to a component of the immune system, such as a receptor or antigen of B cells, T cells, neutrophils, monocytes and macrophages, and dendritic cells, a modulator of coagulation, or a proinflammatory cytokine. The multispecific antagonists are used in the treatment of various diseases that are generated or exacerbated by, or otherwise involve, proinflammatory effectors of the innate immune system or coagulation factors. Such diseases more particularly include acute and chronic inflammatory disorders, autoimmune diseases, giant cell arteritis, septicemia and septic shock, coagulopathies (including diffuse intravascular coagulation), neuropathies, graft versus host disease, infectious diseases, acute respiratory distress syndrome, granulomatous diseases, transplant rejection, asthma, cachexia, myocardial ischemia, and atherosclerosis. Other diseases also responsive to these therapies include cancers and conditions with pathological angiogenesis.
Patent AU-2012201364-B2 (AU)
Title: High concentration antibody formulations
Inventor: Zhou xiao-hong
IPC: A61K47/00
Filed: 2012-03-07
Granted: 2015-08-27
Abstract: Abstract The present disclosure relates to, inter alia, stable aqueous solutions comprising a high concentration of an antibody that binds to human complement component C5 and methods for preparing the solutions. The disclosure also provides methods for treating or preventing complement-associated disorders (for example, age-related macular degeneration or rheumatoid arthritis) using the solutions. Also featured are therapeutic kits containing one or more of the solutions and a means for administering the solutions to a patient in need such a treatment.
Patent AU-2012216472-B2 (AU)
Title: Data Logging and Tracking System
Inventor: YOUNG OLIVER
IPC: G06F15/16
Filed: 2012-08-28
Granted: 2014-03-27
Abstract: A Web based incremental/periodic upload type tracking system comprising: a data logger for logging of data at predetermined logging intervals; said data logger having a data export mechanism for export of tracking data derived from said data; a web accessible database; a web connectable transmitter for transmission of said tracking data to said web accessible database. 15 (Multiple) Loggers 10 KPI's Li Web-based L3 27 Database L MAP OVERLAY Logger-132 13 20 22 Time t 1 t 2 t 3 Co-ord X1Y1Z1 X2Y2Z2 X Y" SAt\ Fig. 1
Patent AU-2012243067-B2 (AU)
Title: Biopsy device with motorized needle firing
Inventor: FEIBIG KEVIN M
IPC: A61B10/02
Filed: 2012-04-10
Granted: 2014-05-15
Abstract: A biopsy device comprises a needle, a body portion, and a needle firing assembly. The needle firing assembly is operable to fire the needle distally relative to the body portion. The needle firing assembly includes two translating members, a resilient member, and a motor. The motor is operable to selectively move the first translating member distally and proximally. The second translating member is secured relative to the needle such that the needle and the second translating member translate unitarily. The resilient member compresses as the first translating member is moved distally toward the second translating member. The first translating member is then secured to the second translating and the translating members are moved proximally while holding the resilient member in the compressed state. The second translating member is released from the first translating member when they reach a proximal position, which allows the resilient member to fire the needle distally.
Patent AU-2012286580-B2 (AU)
Title: Contact lenses
Inventor: ROSSER IAN NEIL DOUGLAS
IPC: G02C7/04
Filed: 2012-06-28
Granted: 2014-10-09
Abstract: A contact lens for application to the cornea of an eye comprising (a) a peripheral area having dot colour matrix; and (b) a central area having a base tint.
Patent AU-2012301974-B2 (AU)
Title: Removable strain relief brackets for securing fiber optic cables and/or optical fibers to fiber optic equipment, and related assemblies and methods
Inventor: COTE MONIQUE LISE
IPC: G02B6/44
Filed: 2012-08-30
Granted: 2016-05-19
Abstract: Removable strain relief brackets for securing fiber optic cables (44) and/or optical fiber to fiber optic equipment, and related assemblies and methods are disclosed. The removable strain relief brackets comprise lances (48) protruding from a platform and receiving cable ties (40) for securing optical fibre cables (44). The platform is mounted on a tray surface (26) or the like via pin fastener (134) and an angled tab (140, 132) received in a mounting part (102) of the tray surface.
Patent AU-2012306587-B2 (AU)
Title: Electromagnetic drive
Inventor: BOTTCHER MARTIN
IPC: H01H3/28
Filed: 2012-08-23
Granted: 2016-07-28
Abstract: The invention relates to,
Patent AU-2012315699-B2 (AU)
Title: Compounds for improved viral transduction
Inventor: HEFFNER GARRETT COLLINS
IPC: C12N7/01
Filed: 2012-09-28
Granted: 2017-08-17
Abstract: The present invention provides methods and compositions for improving the efficacy of viral transduction of cells. More particularly, the present invention provides methods and materials useful for safely and reliably improving the efficiency of methods for transducing cells, such as human hematopoietic stem cells (HSC), with viruses and/or viral vectors. The compositions and methods are useful for therapeutic indications amenable to treatment with hematopoietic stem cell gene therapies.
Patent AU-2012346755-B2 (AU)
Title: Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases
Inventor: LEE JONG-WOOK
IPC: A61K31/42
Filed: 2012-11-28
Granted: 2016-09-15
Abstract: The present invention provides a pharmaceutical composition for preventing or treating hyperlipidemia comprising (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one or its pharmaceutically acceptable salt; and a calcium channel blocker or a fibrate as active ingredients.